Health Care & Life Sciences » Pharmaceuticals | JW Pharmaceutical Corp.

JW Pharmaceutical Corp.

JW Pharmaceutical Corp.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW66.42
Market Cap
KRW632.13 B
Shares Outstanding
20.32 M
Public Float
11.28 M
JW Pharmaceutical Corp. Pfd. Series 2
Stock Exchange Korea Exchange Commodity Market
EPS
-
Market Cap
KRW1.05 T
Shares Outstanding
86.1 K
Public Float
-
JW Pharmaceutical Corp. Pfd. Series 1
Stock Exchange Korea Exchange Commodity Market
EPS
KRW66.42
Market Cap
KRW524.77 B
Shares Outstanding
167.38 K
Public Float
160 K

Profile

Address
JW Tower
Seoul SL 06725
Korea, Republic Of
Employees -
Website http://www.jw-pharma.co.kr
Updated 07/08/2019
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. Its products include analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, antifungal agents, circulatory system agents, gastrointestinal agents, miscellaneous, multivitamins and anti-anemic agents, contact lens care and ophthalmic agents, topicals, amino acid solutions, flexible intravenous container, intravenous solutions, respiratory agents, obstetrics and gynecology agents, nephrology agents, central nervous system, urology agents, and diabetic agents. The company was founded on August 8, 1945 and is headquartered in Seoul, South Korea.

Financials

View All

Kyung-Ha Lee
Chairman
Yeong-Seob Shin
Co-CEO, Director & Head-Pharmaceutical Business